The Triglyceride Glucose (TyG) index is a new and sensitive marker of Insulin Resistance (IR). Its relationship with a 10-year cardiovascular risk (CVD) in hypertensives in Nigeria is currently unknown. This was a cross-sectional study involving 1,430 adult Nigerians with hypertension. The TyG index of subjects was divided into quartiles (Q1-Q4), and its association with 10-year CVD risk using Framingham 10-year Cardiovascular Risk Score was explored. The mean age of the study population was 55.8 ± 13.9 years with a male preponderance of 54.1%. The mean TyG index was 8.72 ± 0.6 with a significantly higher value in males (8.77 ± 0.6 vs 8.67 ± 0.5; p = 0.001). This trend was consistent across all age groups. The prevalence of elevated TyG index was 51.9% and 44.7% in males and females respectively. Using ROC the cut-offs that predicted moderate to high CVD risk were 8.85 (0.69(0.57-0.80; 95% CI; p = 0.001) and 8.74 (0.688 (0.59-0.78; 95% CI; p = 0.001) for males and females respectively. After adjustment for well-known risk factors, an elevated TyG index was associated with an increased 10-year CVD risk in females only. The TyG index is associated with an increased 10-year cardiovascular risk especially in females and a value of at least 8.7 is reasonably accurate to predict a 10-year CVD risk in Nigerians with hypertension.
Hypertension remains the leading modifiable risk factor for global morbidity and mortality, disproportionately affecting low- and middle-income countries (
Background: Studies exploring the relationship between serum uric acid (sUA) and cardiovascular risk in the Nigerian population remain sparse. The study aimed to assess the association between sUA levels and two measures of cardiovascular risk, namely the Framingham 10-year Cardiovascular Risk Score (FRS) and the Atherogenic Index of Plasma (AIP).
The hypertriglyceridemic waist (HTGW) phenotype was introduced as a means of identifying individuals at risk of developing metabolic syndrome as well as cardiovascular diseases and diabetes. However, studies surrounding the prevalence of the phenotype and its relationship with established markers of cardiometabolic risk, especially in the Nigerian population, remain sparse. This study aimed to determine the prevalence of the HTGW phenotype and explore its relationship with cardiovascular risk markers, namely Castelli Risk Indices I and II (CRI-I and CRI-II), Atherogenic Index of Plasma (AIP) and serum triglyceride-HDL cholesterol ratio (TG/HDL). In this retrospective cross-sectional study, the records of 206 patients presenting at a cardiac hospital from November 2022 to October 2023 were analysed. The HTGW phenotype was deemed present with a waist circumference of at least 94cm in men or 80cm in women and a serum triglyceride level of 150mg/dl or more in both sexes. At-risk waist circumference was more prevalent in women (92.7% vs 77.3%; p=0.002). The prevalence of the HTWG phenotype in the patient cohort was 29.6%, with more males than females (31.8% vs 27.1%) presenting with the phenotype (p=0.004). Patients with the phenotype also had higher systolic blood pressure, waist circumference, body mass index, triglycerides, AIP, and TG/HDL (all p<0.0005). The HTWG phenotype was also associated with a lower HDL and LDL cholesterol (p<0.0005) as well as a lower CRI-II (p=0.049). The HTWG phenotype correlates with an increased cardiometabolic risk among Nigerians. This finding warrants the implementation of routine anthropometric and serum triglyceride measurements in screening programmes and hospitals for the early detection of individuals at risk of developing cardiovascular diseases.
25 February 2024 in Journal of Clinical Medicine of Kazakhstan
Background: Monogenic hypertension syndromes result from a single genetic mutation and present with severe, refractory hypertension, distinct laboratory abnormalities, and a positive family history. These syndromes are often unrecognized or misdiagnosed as essential hypertension, thus preventing proper treatment. The rise of molecular genetics has brought these conditions to the limelight, and physicians must be kept abreast of the latest in this field. This paper aims to educate doctors to recognize and institute appropriate management early to prevent end-organ damage. Discussion: These syndromes all affect sodium transport in the distal nephron of the kidneys. However, they are divided based on the location of the primary disorder, i.e., the adrenal glands or the distal nephron and discussed in that manner. Tables provide an overview of the different syndromes and provide essential information in a snapshot. Conclusion: The widespread availability of genetic testing facilities will aid in the earlier diagnosis of these conditions to prevent morbidity.